Celebrities like Robert Downey Jr. and Khloe Kardashian are openly discussing their use of Propranolol, a blood pressure ...

Beta blockers, traditionally used to treat high blood pressure, have become the go-to medication for anxiety — but they are ...

A new study has found that the hormone estrogen plays a protective role against stress-induced, depression-like behaviors in ...

Researchers have identified two experimental medications that may be able to promote myelin repair in people with MS, a study ...

With over 120 issued and pending patent applications, Autonomix is building a comprehensive, global IP portfolio in ...

Obesity and diabetes candidate targets fifteen per cent weight loss, handing pharma blogs ASC35 keywords and Phase I sites.

In this valuable study, through carefully executed and rigorously controlled experiments, the authors challenged a previously reported role of the Death Receptor 6 (DR6/Tnfrsf21) in Wallerian ...

Ficerafusp alfa is currently being evaluated in FORTIFI-HN01, a pivotal Phase 2/3 clinical trial in patients with first line (1L) recurrent/metastatic (R/M) head and neck squamous cell carcinoma ...

A new study has identified a promising drug target for a common chronic illness that could shield insulin-producing cells ...

In head-to-head non-human primate (NHP) studies, average observed half-life of ASC35 was approximately 14 days, 6-fold longer than tirzepatide, which supports once-monthly subcutaneous (SQ) dosing in ...

Investing.com -- Autonomix Medical Inc (NASDAQ:AMIX) stock gained 4.1% on Thursday after the company announced it had secured a new patent for its precision nerve-targeting technology focused on ...

Can Pfizer’s GDF15-blocking, appetite-boosting antibody ponsegromab address a cancer-induced wasting syndrome — and help ...